A clinical stage biopharmaceutical company focused on the development of novel, small molecule therapeutics for respiratory disorders including asthma, COPD, IPF and allergic rhinitis...
Forward Therapeutics is a biopharmaceutical company dedicated to transforming the treatment of chronic inflammatory disorders. The company is advancing a pipeline of novel, next-generation small molecule immune therapies...
MiNK Therapeutics is a clinical-stage precision oncology company developing allogeneic, invariant natural killer T cell therapies for cancer and other immune-mediated diseases. The lead product is an off-the-shelf, cell therapy based on a targeted..
Pathalys is a private, late-stage clinical biopharmaceutical company committed to the development of multiple advanced therapeutics that address unmet needs in the management of late stage chronic kidney disease (CKD)... Pathalys was created with..
Gencyte Therapeutics is focused on the development of the next-generation of Chimeric Antigen Receptor T-cell (CAR-T) immunotherapy for precision cancer treatment... We believe that the time is right for a new approach. We believe that there is an..
Glycadia is a clinical-stage biopharmaceutical company developing therapeutics for the prevention and treatment of kidney, eye, cardiovascular and related diseases that result from diabetes...
TGV-Therapeutics is a biopharmaceutical company focused on the development of novel drugs that can address unmet clinical needs in the treatment of life-threatening systemic fungal infections...
Confluence Discovery Technologies is an indirectly wholly owned subsidiary of Aclaris Therapeutics, Inc. (NASDAQ:ACRS). Aclaris is a dermatologist-led biopharmaceutical company committed to identifying, developing, and commercializing innovative..
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health..
Innovex Therapeutics S.L. is a biotechnology company that uses Extracellular Vesicles as Vaccines against infectious diseases with the goal of global health equity... We have developed an innovative exosome-based vaccine platform featuring a novel..
Quell Therapeutics is a London, UK based, private biopharmaceutical company. Our vision is to be the leading engineered cell therapy company, bringing transformational and valued therapies addressing a range of autoimmune and inflammatory diseases,..
Aevitas Therapeutics is a biopharmaceutical company focused on advancing gene therapies of short-form human factor H (sFH) to restore complement regulation in dry age-related macular degeneration (Dry AMD), atypical hemolytic uremic syndrome (aHUS),..
RAPT Therapeutics is a clinical-stage biopharmaceutical company driven by a bold mission-to treat inflammatory diseases and conquer cancer in our lifetime. Our cutting-edge science is fully focused on developing oral therapeutics that intelligently..
BioCyto is a preclinical stage biopharmaceutical company that is developing a highly versatile portfolio of proprietary biocompatible intranasal and injectable drug delivery systems with superior transportation and administration properties that..
Gilead Sciences Europe Ltd is a research-based biopharmaceutical company that discovers, develops and commercialises innovative medicines... Gilead's mission is to advance patient care by developing therapeutics to treat life-threatening diseases.....
Repare Therapeutics is a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. Repare Therapeutics utilizes its proprietary, genome-wide,..
Neuropathix is a biopharmaceutical company focused on the research and development of a pipeline of next generation socially responsible pain management therapeutics to treat patients with significant unmet medical needs...
Sentynl Therapeutics, Inc. is a US-based specialty pharmaceutical company dedicated to improving patient care through innovative therapeutics... Our goal is to provide novel biopharmaceutical medicines that extend, improve, or enhance the lives of..
Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone... At Mineralys Therapeutics we are focused on developing medicines to target diseases..
Pharmazz, Inc. is an innovative biopharmaceutical company with an approved product, promising drug pipeline focused on discovering, acquiring, developing, and commercializing therapeutics that target critical care medicine...
Lung Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel therapies for underserved, life-threatening lung conditions... At Lung Therapeutics, we have a highly promising product pipeline that features two leading..
MElkin pharma is a biopharmaceutical company dedicated to the discovery and early development of novel therapeutics for the treatment of cancer and brain diseases... MElkin Pharmaceuticals is a biopharmaceutical company founded in 2015. It develops..
Lyra Therapeutics is a clinical-stage company developing medicines precisely designed to target ear, nose and throat (ENT) diseases. Our goal is to transform the ENT treatment..... We are a clinical stage biopharmaceutical company with the goal of..
Nabriva Therapeutics is a commercial-stage biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious infections... Nabriva is a commercial-stage biopharmaceutical company engaged in the research..
Dystrogen Therapeutics is a clinical-stage life sciences company committed to developing personalized therapies for rare genetic diseases... Dystrogen Therapeutics is currently focused on the development of a chimeric cell-based therapy platform...
Healthbridge Therapeutics (SO), an oncology-focused biopharmaceutical company, is seeking a Director of Drug Development to lead drug development efforts for specific programs and contribute more broadly to its efforts to advance its cancer..
IMPACT Therapeutics is a biopharmaceutical company dedicated to the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality. Impact has assembled one of the most comprehensive DNA damage response (DDR) global..
Mizar Therapeutics is a platform therapeutics company using proprietary live-cell single-molecule imaging and machine-learning technology to enable Structure-Activity Relationship (SAR) based drug discovery...
At Blue Cell Therapeutics, our mission is to revolutionize the treatment of erectile dysfunction applying Blue Cell therapy, for men with post-(radical) prostatectomy. We are committed to develop an ‘over the counter' curative allogenic stem cell..
The Bioproduction Congress is the annual event of the biopharmaceutical production sector where stakeholders from Europe gather together to showcase and exchange the latest innovations in bioprocessing. This dynamic event promotes exchanges on the..